Michael DeMane has joined Thomas, McNerney & Partners as a Minneapolis-based senior advisor. He spent the past eight years in various executive roles with Medtronic Inc., most recently as chief operating officer.
Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, today announced that Michael DeMane has joined as Senior Advisor in the firm’s Minneapolis office. From 2000 to 2008, Mr. DeMane held various senior positions at Medtronic Inc.’s (NYSE: MDT) U.S. and global operations, most recently as its Chief Operating Officer.
“Michael is a proven leader in the medical device industry with an unbroken record of global operating success,” said Pete McNerney, Partner. “His extensive knowledge and industry contacts will be a valuable addition to our investment team, both in working with our existing portfolio and in reviewing potential new investments.”
Mr. DeMane has more than 25 years of global medical device experience. Prior to his role as Chief Operating Officer at Medtronic, he served as Senior Vice President and President, Europe, Canada, Latin America and Emerging Markets. Previously he was Senior Vice President and President, Spinal, ENT and Navigation, Medtronic’s fastest growing business sector, where he was responsible for growing the acquired businesses of Sofamor Danek, Xomed and Surgical Navigation Technologies. Prior to joining Medtronic, Mr. DeMane was President, Interbody Technologies, a division of Sofamor Danek and he held various senior positions at Smith & Nephew, Inc. including Managing Director for operations in Australia and New Zealand and President of the Orthopedic Implant Division. “Thomas, McNerney & Partners has extensive investment experience and wide contacts in the medical technology industry,” said Mr. DeMane. “I look forward to assisting them with their portfolio companies and investment process.”
About Thomas, McNerney & Partners
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. The firm has offices in Minneapolis, Stamford and San Francisco. For further information, please visit www.tm-partners.com.